Unexplained pancytopenia in acute myeloid leukemia treatment

Certain histopathological findings have been described in acute myeloid leukemia (AML) patients during treatment that define the hematologic outcomes. Such entities as bone marrow necrosis and hemophagocytic lymphohistiocytosis have been reported. These often result in severe pancytopenia.

Detalles Bibliográficos
Autores principales: Ezekwudo, Daniel, Lupak, Oleksandra, Vaddepally, Raju, Gbadamosi, Bolanle, Kuriakose, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099047/
https://www.ncbi.nlm.nih.gov/pubmed/30147892
http://dx.doi.org/10.1002/ccr3.1570
_version_ 1783348582367100928
author Ezekwudo, Daniel
Lupak, Oleksandra
Vaddepally, Raju
Gbadamosi, Bolanle
Kuriakose, Philip
author_facet Ezekwudo, Daniel
Lupak, Oleksandra
Vaddepally, Raju
Gbadamosi, Bolanle
Kuriakose, Philip
author_sort Ezekwudo, Daniel
collection PubMed
description Certain histopathological findings have been described in acute myeloid leukemia (AML) patients during treatment that define the hematologic outcomes. Such entities as bone marrow necrosis and hemophagocytic lymphohistiocytosis have been reported. These often result in severe pancytopenia.
format Online
Article
Text
id pubmed-6099047
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60990472018-08-24 Unexplained pancytopenia in acute myeloid leukemia treatment Ezekwudo, Daniel Lupak, Oleksandra Vaddepally, Raju Gbadamosi, Bolanle Kuriakose, Philip Clin Case Rep Case Reports Certain histopathological findings have been described in acute myeloid leukemia (AML) patients during treatment that define the hematologic outcomes. Such entities as bone marrow necrosis and hemophagocytic lymphohistiocytosis have been reported. These often result in severe pancytopenia. John Wiley and Sons Inc. 2018-06-19 /pmc/articles/PMC6099047/ /pubmed/30147892 http://dx.doi.org/10.1002/ccr3.1570 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Ezekwudo, Daniel
Lupak, Oleksandra
Vaddepally, Raju
Gbadamosi, Bolanle
Kuriakose, Philip
Unexplained pancytopenia in acute myeloid leukemia treatment
title Unexplained pancytopenia in acute myeloid leukemia treatment
title_full Unexplained pancytopenia in acute myeloid leukemia treatment
title_fullStr Unexplained pancytopenia in acute myeloid leukemia treatment
title_full_unstemmed Unexplained pancytopenia in acute myeloid leukemia treatment
title_short Unexplained pancytopenia in acute myeloid leukemia treatment
title_sort unexplained pancytopenia in acute myeloid leukemia treatment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099047/
https://www.ncbi.nlm.nih.gov/pubmed/30147892
http://dx.doi.org/10.1002/ccr3.1570
work_keys_str_mv AT ezekwudodaniel unexplainedpancytopeniainacutemyeloidleukemiatreatment
AT lupakoleksandra unexplainedpancytopeniainacutemyeloidleukemiatreatment
AT vaddepallyraju unexplainedpancytopeniainacutemyeloidleukemiatreatment
AT gbadamosibolanle unexplainedpancytopeniainacutemyeloidleukemiatreatment
AT kuriakosephilip unexplainedpancytopeniainacutemyeloidleukemiatreatment

Ejemplares similares